Stay updated with breaking news from Christian rommel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Bayer-owned drug developer received special fast-track status from U.S. regulators for its Parkinson s disease treatment following positive phase-1 trials.
LEVERKUSEN (dpa-AFX) - German pharmaceutical and life sciences major Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Thursday that its clinical stage cell therapy unit BlueRock Therapeutics LP's ....